Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Mullen

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Cancer|September 14, 2020
A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 studyJames I Geller, Nicholas G Cost, Yueh-Yun Chi, et al.
AJR. American Journal of Roentgenology|March 12, 2020
Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2Jesse K Sandberg, Yueh-Yun Chi, Ethan A Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Authors' Reply to the Letter to the Editor by Daniel M. GreenJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: renal tumorsJeffrey S Dome, Conrad V Fernandez, Elizabeth A Mullen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2019
Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 studyNajat C Daw, Yueh-Yun Chi, Yeonil Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms TumorJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2023
Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of ChemotherapyNatanja Oosterom, Saskia L M Gooskens, Lindsay A Renfro, et al.
Cancer|October 30, 2023
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532Nicholas Evageliou, Lindsay A Renfro, James Geller, et al.
Cancer|January 13, 2025
Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studiesAmy E Armstrong, Najat C Daw, Lindsay A Renfro, et al.
JCO Precision Oncology|May 14, 2026
Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN StudyHolly J Roberts, Hannah Comeau, Kelly Klega, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Cancer|September 14, 2020
A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 studyJames I Geller, Nicholas G Cost, Yueh-Yun Chi, et al.
AJR. American Journal of Roentgenology|March 12, 2020
Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2Jesse K Sandberg, Yueh-Yun Chi, Ethan A Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
Authors' Reply to the Letter to the Editor by Daniel M. GreenJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: renal tumorsJeffrey S Dome, Conrad V Fernandez, Elizabeth A Mullen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2019
Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 studyNajat C Daw, Yueh-Yun Chi, Yeonil Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms TumorJeffrey S Dome, Elizabeth A Mullen, David B Dix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2023
Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of ChemotherapyNatanja Oosterom, Saskia L M Gooskens, Lindsay A Renfro, et al.
Cancer|October 30, 2023
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532Nicholas Evageliou, Lindsay A Renfro, James Geller, et al.
Cancer|January 13, 2025
Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studiesAmy E Armstrong, Najat C Daw, Lindsay A Renfro, et al.
JCO Precision Oncology|May 14, 2026
Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN StudyHolly J Roberts, Hannah Comeau, Kelly Klega, et al.
Pageof 8